M. Ibanoglu, C. Kose, Tugce Kacan, Kadriye Erdogan, Sinan Karadeni̇z, S. Erkaya, Y. Ustun
{"title":"Evaluation of the effects of different progesterone treatment methods on fetal aneuploidy screening tests","authors":"M. Ibanoglu, C. Kose, Tugce Kacan, Kadriye Erdogan, Sinan Karadeni̇z, S. Erkaya, Y. Ustun","doi":"10.47572/muskutd.1095993","DOIUrl":null,"url":null,"abstract":"Objective In this study, the effect of progesterone use on biomarkers due to abortion complaints in aneuploidy screenings was investigated. \nStudy Design Two hundred seventy-six singleton pregnant patients with threatened abortion were enrolled in this retrospective study. The treatment group consisted of patients who received oral, vaginal, or intramuscular progesterone (n=137) while the control group received no progesterone (n=139). The results of the double and triple screening tests of the study groups were compared. \nResults Nuchal translucency measurements and pregnancy-associated plasma protein-A (PAPP-A), (MoM) values were significantly lower in the group that received treatment with progesterone compared to the control group (p=0.009 and p","PeriodicalId":153630,"journal":{"name":"Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi","volume":"614 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47572/muskutd.1095993","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective In this study, the effect of progesterone use on biomarkers due to abortion complaints in aneuploidy screenings was investigated.
Study Design Two hundred seventy-six singleton pregnant patients with threatened abortion were enrolled in this retrospective study. The treatment group consisted of patients who received oral, vaginal, or intramuscular progesterone (n=137) while the control group received no progesterone (n=139). The results of the double and triple screening tests of the study groups were compared.
Results Nuchal translucency measurements and pregnancy-associated plasma protein-A (PAPP-A), (MoM) values were significantly lower in the group that received treatment with progesterone compared to the control group (p=0.009 and p